Lundbeck
HLUN-B.CO
#2415
Rank
$6.06 B
Marketcap
$6.36
Share price
-0.18%
Change (1 day)
30.03%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2024 (TTM): $0.46 Billion USD

According to Lundbeck 's latest financial reports the company's current earnings are $2.98 Billion USD. In 2023 the company made an earning of $0.44 Billion USD, an increase over its 2022 earnings that were of $0.36 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $0.46 B5.97%
2023 $0.44 B21.69%
2022 $0.36 B31.79%
2021 $0.27 B-4.53%
2020 $0.28 B-45.08%
2019 $0.52 B-33.97%
2018 $0.79 B12.76%
2017 $0.70 B94.32%
2016 $0.36 B-136.98%
2015 -$0.99 Billion-1258.1%
2014 $84.76 M-72.43%
2013 $0.30 B4.31%
2012 $0.29 B-55.26%
2011 $0.65 B6.64%
2010 $0.61 B-6.68%
2009 $0.66 B